title: Successful maintenance of continuous ambulatory peritoneal dialysis in a patient after fungal peritonitis and dialysate leakage.
abstract: Fungal peritonitis (FP) and dialysate leakage have often been reported in association with continuous ambulatory peritoneal dialysis (CAPD), which has to be discontinued in many cases due to these complications. This report describes the first case of dialysate leakage into the urinary bladder of a 70-year-old male patient, after the area of the left ureteral ostium had been very deeply resected. The leakage probably led to severe fungal peritonitis developing 1 day after the ostium resection. The ostium resection was performed in November 2003 after detection of a carcinoma in situ (Cis) in this area and after previous bilateral nephroureterectomies due to multifocal urothelial carcinoma in the kidneys, ureters and bladder. In spite of prior fungal peritonitis and dialysate leakage, CAPD could be successfully initiated 41 days after biochemical manifestation of peritonitis and could be maintained in the patient because of the following reasons: early and effective treatment of FP with fluconazole and voriconazole, spontaneous occlusion of the slitted ostium area, allowance of enough healing time after 2 major abdominal surgeries, during which the patient was placed on extracorporal hemodialysis (which had been started 1 day after nephroureterectomy and ended after the antimycotic treatment) and thorough monitoring of the patient after starting CAPD. In January 2004, the patient could be placed on a cycler peritoneal dialysis and was fully rehabilitated 1 year later.
authors.affiliation: Center of Nephrology, Mettmann, Germany. Koch@dialyse-mettmann.de
authors.forename: M
authors.initials: M
authors.lastname: Koch
authors.forename: R
authors.initials: R
authors.lastname: Trapp
authors.forename: M
authors.initials: M
authors.lastname: Goepel
mesh_terms: D000368:Aged; D041221:Candida glabrata; D002177:Candidiasis / Q000209:etiology*; D015314:Dialysis Solutions; D006801:Humans; D008297:Male; D009392:Nephrectomy / Q000009:adverse effects*; D010531:Peritoneal Dialysis, Continuous Ambulatory; D010538:Peritonitis / Q000382:microbiology*; D051437:Renal Insufficiency / Q000209:etiology / Q000628:therapy*; D014513:Ureter / Q000601:surgery*; D001743:Urinary Bladder
chemical_list: D015314:Dialysis Solutions